Featured Research

from universities, journals, and other organizations

Study Tests Reliability Of More Accurate Measure Of Patient Pain

Date:
March 12, 2009
Source:
Wiley-Blackwell
Summary:
A new study shows the reliability a newly developed device for assessing pain. This device is called the continuous pain score meter. It enables continuous real time pain score measurement, which is used to obtain exact measurements of pain intensity in humans during the course of a procedure. The findings provide more detailed information on patients' pain perception and may lead to better pain management for certain clinical procedures.

A new study appearing in Pain Practice successfully shows the reliability a newly developed device for assessing pain. This device is called the continuous pain score meter (CPSM). It enables continuous real time pain score measurement, which is used to obtain exact measurements of pain intensity in humans during the course of a procedure.

The findings provide more detailed information on patients’ pain perception and may lead to better pain management for certain clinical procedures.

The ability to accurately measure pain intensity, pain duration and the effect of analgesics is an important task in both medical practice and research. The sharp increase in present-day office procedures, without general anesthesia, has made this even more important. The CPSM procedure can be valuable to study pain intensity in clinical procedures that take between 1-30 minutes.

Currently, there are various validated instruments available to assess pain in patients. The visual analog score (VAS) is the most widely used scale. The VAS scale measures pain by a single score indicated by a patient the end of a procedure. It uses a scale that ranges from “no pain” to “worst imaginable pain.” The VAS is frequently used for diagnostic and technical procedures to evaluate patient tolerance in an office setting.

This method, however, has three major disadvantages. If a procedure consists of multiple different actions, pain intensity may vary according to each action. This important information is not detected by a single measurement afterwards. Second, pain intensity measurements after the procedure may be biased by the inaccuracy of the memory to recall pain sensations. Third, pain is by nature not a short, limited phenomenon; pain sensation does not suddenly stop after a stimulus, but gradually disappears, requiring continuous measurements in order to fully cover the pain sensation. With this new pain score meter it is possible to measure pain continuously throughout the procedure. In this way, a clinician gains more insight into the patients’ pain perception.

The study used thirty-two healthy volunteers who received a reproducible pain stimulus at one-minute intervals. The stimulus was induced by a dolorimeter, an instrument that applies continuously increasing pressure, on the thumbnail and forearm, as these points are easily accessible and have a low pain threshold. During the stimulus, pain was continuously measured with the CPSM, providing values of peak continuous pain score (peak CPS) and area under the continuous pain score curve (AUC CPS).

“The additional knowledge provided by the CPSM can be very helpful in clinical settings to optimize the use of local analgesia in diagnostic or therapeutic procedures or to adapt the technique into more tolerable procedures,” says Dr. Paul van Kesteren, co-author of the study. “Therefore, the CPSM seems to be a better option than conventional techniques for real-time continuous measurement of a subject’s pain intensity with adequate reliability.”


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. Boormans et al. Reliability of a Continuous Pain Score Meter: Real Time Pain Measurement. Pain Practice, 2009; 9 (2): 100 DOI: 10.1111/j.1533-2500.2009.00260.x

Cite This Page:

Wiley-Blackwell. "Study Tests Reliability Of More Accurate Measure Of Patient Pain." ScienceDaily. ScienceDaily, 12 March 2009. <www.sciencedaily.com/releases/2009/03/090309131721.htm>.
Wiley-Blackwell. (2009, March 12). Study Tests Reliability Of More Accurate Measure Of Patient Pain. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/03/090309131721.htm
Wiley-Blackwell. "Study Tests Reliability Of More Accurate Measure Of Patient Pain." ScienceDaily. www.sciencedaily.com/releases/2009/03/090309131721.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins